Market statusEarly Stage Concept

Products 51 to 60 of 69

Non-browning Lettuce by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (2 years ago)
Date last modified: 2019/09/12 15:12 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food + Plant
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Finished Product
Non-browning Pears by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:11 (2 years ago)
Date last modified: 2019/09/12 15:11 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
OG716: Lantibiotics by Oakbio + Oragenics
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (2 years ago)
Date last modified: 2019/09/12 15:16 (2 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial + Government + TBD
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 295,172 USD
Funding types: Government + Venture Capital
Industry: Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Soil Amendment + Medical Treatment + Other (Industrial)
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Pomecin by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/02 15:44 (3 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Porcupine (synthetic DNA tagging system) by University of Washington
Biotech components: Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:51 (4 months ago)
Date last modified: 2020/12/18 14:51 (4 months ago)
Known funding amount: N/A
Funding types: University
Industry: Multipurpose + Novelty
Market status: Early Stage Concept
Organization type(s): University
Product categories: Other
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Input + Platform
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: North America + Africa + Europe + Asia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/02 06:17 (3 years ago)
Known funding amount: 8,946 USD
Funding types: Crowdfunding
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Salk Ideal Plants by Salk Institute for Biological Studies
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:08 (2 years ago)
Date last modified: 2019/09/12 15:08 (2 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Ecosystem Restoration + Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (2 years ago)
Date last modified: 2019/09/12 14:53 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Ecosystem Restoration + Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (2 years ago)
Date last modified: 2019/09/12 14:53 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product